Maas BiolabsMaas Biolabs
Maas Biolabs

Maas Biolabs

AI-powered platform for accelerating biological research and drug discovery.

2022Active

About

Maas Biolabs is developing an AI-powered platform designed to accelerate biological research and drug discovery. Their technology aims to analyze complex biological data, identify potential drug candidates, and optimize experimental workflows for researchers and pharmaceutical companies.

Technology stack

detected 2026-06-18
Est. monthly stack spend~$70/mo
Emailnone
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Maas Biolabs do?

Maas Biolabs is developing an AI-powered platform designed to accelerate biological research and drug discovery. Their technology aims to analyze complex biological data, identify potential drug candidates, and optimize experimental workflows for researchers and pharmaceutical companies.

How much funding has Maas Biolabs raised?

Maas Biolabs has raised a total of $12M in funding. The most recent round on record is Seed.

Where is Maas Biolabs headquartered?

Maas Biolabs is headquartered in San Francisco, United States.

When was Maas Biolabs founded?

Maas Biolabs was founded in 2022.

What industry does Maas Biolabs operate in?

Maas Biolabs operates in Biotech, Drug Discovery, AI-Driven Protein Design, Genomics, HealthTech, Foundation Model.